Refocus Inc logo

RFCS - Refocus Inc Share Price

$0.042 0.0  0.0%

Last Trade - 04/03/21

Micro Cap
Market Cap £749k
Enterprise Value £2.07m
Revenue £n/a
Position in Universe th / 6651
Unlock RFCS Revenue
Relative Strength (%)
1m +108.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -85.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 1999 2000 2001 2002 2003 2004 2005E 2006E CAGR / Avg
0.000 1.31 0.23 0.000 0.000 0.000 -100.0%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2005, RefocusGroup, Inc. revenues was not reported. Net loss increased31% to $4M. Higher net loss reflects Stock-basedCompensation increase from $153K to $565K (expense),Clinical Trials increase of 44% to $1.2M (expense),Research & Development increase from $33K to $119K(expense). Basic Earnings per Share excluding ExtraordinaryItems decreased from -$0.13 to -$0.16.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


RFCS Revenue Unlock RFCS Revenue

Net Income

RFCS Net Income Unlock RFCS Revenue

Normalised EPS

RFCS Normalised EPS Unlock RFCS Revenue

PE Ratio Range

RFCS PE Ratio Range Unlock RFCS Revenue

Dividend Yield Range

RFCS Dividend Yield Range Unlock RFCS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RFCS EPS Forecasts Unlock RFCS Revenue
Profile Summary

Refocus Group, Inc. is a medical device company. The Company is engaged in the research and development of treatments for human vision disorders. The Company's VisAbility is a medical device, which is designed to improve near vision that is performed in both eyes. The Company's treatment for presbyopia can restore the natural ability to focus at near and intermediate distances, without considering the distance vision. The Company's VisAbility Micro-Inserts are precision-molded from a clear plastic material. The Company's VisAbility Procedure is a minimally invasive outpatient procedure, which typically takes 15 to 20 minutes per eye. The Company's VisAbility Procedure consists of inserting four tiny implants in the white part of the eye, referred as the sclera. These implants open the space where the focusing muscles are located, referred as the circumlental space (CLS).

Last Annual December 31st, 2004
Last Interim September 30th, 2005
Incorporated January 14, 2003
Public Since March 7, 2003
No. of Shareholders: 384
No. of Employees: 4
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Pink Sheets on Nasdaq
Shares in Issue 24,669,105
Free Float (0.0%)
Eligible for
RFCS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RFCS
Upcoming Events for RFCS
Frequently Asked Questions for Refocus Inc
What is the Refocus Inc share price?

As of 04/03/21, shares in Refocus Inc are trading at $0.042, giving the company a market capitalisation of £749k. This share price information is delayed by 15 minutes.

How has the Refocus Inc share price performed this year?

Shares in Refocus Inc are currently trading at $0.042 and the price has moved by -44% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Refocus Inc price has moved by -56.3% over the past year.

What are the analyst and broker recommendations for Refocus Inc?

There are no analysts currently covering Refocus Inc.

When will Refocus Inc next release its financial results?

Refocus Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2006-09-30
What is the Refocus Inc dividend yield?

Refocus Inc does not currently pay a dividend.

Does Refocus Inc pay a dividend?

Refocus Inc does not currently pay a dividend.

When does Refocus Inc next pay dividends?

Refocus Inc does not currently pay a dividend.

How do I buy Refocus Inc shares?

To buy shares in Refocus Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Refocus Inc?

Shares in Refocus Inc are currently trading at $0.042, giving the company a market capitalisation of £749k.

Where are Refocus Inc shares listed? Where are Refocus Inc shares listed?

Here are the trading details for Refocus Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: RFCS
What kind of share is Refocus Inc?

We were not able to load our ranking data for Refocus Inc

Is there a Refocus Inc share price forecast 2021?

We were not able to load any forecast data for Refocus Inc.

How can I tell whether the Refocus Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Refocus Inc. Over the past six months, the relative strength of its shares against the market has been -61.66%. At the current price of $0.042, shares in Refocus Inc are trading at -40.79% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Refocus Inc PE Ratio?

We were not able to find PE ratio data for Refocus Inc.

Who are the key directors of Refocus Inc?

Refocus Inc's management team is headed by:

Grady Schleier - DRC
Glen Bradley - CHM
Mark Cox - CFO
Kenneth Elmgren - DRC
Thomas Lyles - DRC
Douglas Williamson - CEO
Zack Thompson - CFO
Who are the major shareholders of Refocus Inc?

Here are the top five shareholders of Refocus Inc based on the size of their shareholding:

Similar to RFCS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.